Literature DB >> 26253577

Validation of ethnomedicinal potential of Tinospora cordifolia for anticancer and immunomodulatory activities and quantification of bioactive molecules by HPTLC.

Manju Bala1, Kunal Pratap2, Praveen Kumar Verma1, Bikram Singh3, Yogendra Padwad4.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Tinospora cordifolia (Willd.) Miers ex Hook. f. & Thomas. (Menispermaceae) is one of the most widely used plants in various traditional medicinal systems including "Ayurveda". The plant is used for the treatment of jaundice, rheumatism, urinary disorder, skin diseases, diabetes and anemia. The phytoconstituents present in the plant belongs to different class of compounds such as alkaloids, diterpenoids lactones, glycosides, steroids, phenol, aliphatic compounds and polysaccharides. AIM OF THE STUDY: The aim of present study was the isolation, structure elucidation, quantification and pharmacological evaluation of secondary metabolites from T. cordifolia for anticancer and immunomodulatory activities.
MATERIALS AND METHODS: Different extracts and fractions were prepared from the stem of T. cordifolia. Pure molecules were isolated using normal phase chromatography and characterized on the basis of NMR and mass spectroscopic techniques. The anti-cancer and immunomodulatory activities of different extracts, fractions and isolated compounds were evaluated against four different human cancer cell lines, KB (human oral squamous carcinoma), CHOK-1 (hamster ovary), HT-29 (human colon cancer) and SiHa (human cervical cancer) and murine primary cells respectively. A simple, normal phase HPTLC method was also developed for the quantification of three bioactive compounds i.e N-formylannonain (1), 11-hydroxymustakone (5) and yangambin (8) in the stem of T. cordifolia hosted on fifteen different plants.
RESULTS: Chromatographic purification of different fractions led to the isolation of eight pure molecules i.e N-formylannonain (1), magnoflorine (2), jatrorrhizine (3) palmatine (4), 11-hydroxymustakone (5), cordifolioside A (6), tinocordiside (7) and yangambin (8). All extracts and fractions were active against KB and CHOK-1 cells whereas among the pure molecules palmatine (4) was found to be active against KB and HT-29; tinocordiside (7) against KB and CHOK-1; yangambin (8) against KB cells however N-formylannonain (1) and 11-hydroxymustakone (5), was found active for immunomodulatory activity. HPTLC quantification of three active molecules i.e N-formylannonain (1), 11-hydroxymustakone (5), and yangambin (8) were found in highest quantity in the stem of T. cordifolia hosted on Mangifera indica, however, other two active molecules were not quantified due to their insufficient quantity.
CONCLUSION: Eight compounds have been isolated and characterized belonging to different classes. The pharmacological evaluation of extract, fractions and pure molecules revealed the ethnomedicinal value of T. cordifolia for anticancer and immunomodulatory activities.
Copyright © 2015. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Anticancer; HPTLC; Immunomodulatory; Tinospora cordifolia

Mesh:

Substances:

Year:  2015        PMID: 26253577     DOI: 10.1016/j.jep.2015.08.001

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  12 in total

Review 1.  20-Hydroxyecdysone, from Plant Extracts to Clinical Use: Therapeutic Potential for the Treatment of Neuromuscular, Cardio-Metabolic and Respiratory Diseases.

Authors:  Laurence Dinan; Waly Dioh; Stanislas Veillet; Rene Lafont
Journal:  Biomedicines       Date:  2021-04-29

2.  Purification and characterization of RGA2, a Rho2 GTPase-activating protein from Tinospora cordifolia.

Authors:  Mohd Amir; Mohammad Aasif Dar; Asimul Islam; Faizan Ahmad; Md Imtaiyaz Hassan
Journal:  3 Biotech       Date:  2016-03-01       Impact factor: 2.406

3.  Concurrent production and relative quantification of vasicinone from in vivo and in vitro plant parts of Malabar nut (Adhatoda vasica Nees).

Authors:  Jitendriya Panigrahi; Saikat Gantait; Illa C Patel
Journal:  3 Biotech       Date:  2017-08-16       Impact factor: 2.406

4.  Evaluation of Antithrombotic Activities of Solanum xanthocarpum and Tinospora cordifolia.

Authors:  Onila Lugun; Sobharani Bhoi; Priyanka Kujur; D Vinay Kumar; William R Surin
Journal:  Pharmacognosy Res       Date:  2018 Jan-Mar

5.  Tinospora cordifolia extract prevents cadmium-induced oxidative stress and hepatotoxicity in experimental rats.

Authors:  Rathinasamy Baskaran; Lohanathan Bharathi Priya; V Sathish Kumar; Viswanadha Vijaya Padma
Journal:  J Ayurveda Integr Med       Date:  2018-10-11

6.  Synergistic or Additive Pharmacological Interactions between Magnoflorine and Cisplatin in Human Cancer Cells of Different Histological Origin.

Authors:  Estera Okon; Jarogniew J Luszczki; Wirginia Kukula-Koch; Marta Halasa; Agata Jarzab; Daariimaa Khurelbat; Andrzej Stepulak; Anna Wawruszak
Journal:  Int J Mol Sci       Date:  2020-04-19       Impact factor: 5.923

7.  Humoral immune and adjuvant responses of mucosally-administered Tinospora cordifolia immunomodulatory protein in BALB/c mice.

Authors:  Ivan Aranha; Yeldur P Venkatesh
Journal:  J Ayurveda Integr Med       Date:  2018-11-17

8.  Tinospora cordifolia as a potential neuroregenerative candidate against glutamate induced excitotoxicity: an in vitro perspective.

Authors:  Anuradha Sharma; Gurcharan Kaur
Journal:  BMC Complement Altern Med       Date:  2018-10-01       Impact factor: 3.659

9.  Anti-brain cancer activity of chloroform and hexane extracts of Tinospora cordifolia Miers: an in vitro perspective.

Authors:  Anuradha Sharma; Sandeep Kaur Saggu; Rachana Mishra; Gurcharan Kaur
Journal:  Ann Neurosci       Date:  2019-01-01

10.  Berberine and Tinospora cordifolia exert a potential anticancer effect on colon cancer cells by acting on specific pathways.

Authors:  Annalisa Palmieri; Luca Scapoli; Anastasia Iapichino; Laura Mercolini; Manuela Mandrone; Ferruccio Poli; Aldo Bruno Giannì; Camilla Baserga; Marcella Martinelli
Journal:  Int J Immunopathol Pharmacol       Date:  2019 Jan-Dec       Impact factor: 3.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.